• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differences in duration of Huntington's disease based on age at onset.亨廷顿舞蹈症的病程基于发病年龄的差异。
J Neurol Neurosurg Psychiatry. 1999 Jan;66(1):52-6. doi: 10.1136/jnnp.66.1.52.
2
Duration of illness in Huntington's disease is not related to age at onset.亨廷顿舞蹈症的病程与发病年龄无关。
J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):98-100. doi: 10.1136/jnnp.56.1.98.
3
Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.芬兰患者中年发病与晚发亨廷顿病的比较。
J Neurol. 2017 Oct;264(10):2095-2100. doi: 10.1007/s00415-017-8600-2. Epub 2017 Aug 28.
4
Predictors of survival in a Huntington's disease population from southern Italy.意大利南部亨廷顿病患者的生存预测因素。
Can J Neurol Sci. 2012 Jan;39(1):48-51. doi: 10.1017/s0317167100012671.
5
Survival of Huntington's disease patients in Serbia: longer survival in female patients.塞尔维亚亨廷顿舞蹈症患者的生存率:女性患者生存期更长。
Eur J Epidemiol. 2007;22(8):523-6. doi: 10.1007/s10654-007-9157-7. Epub 2007 Jul 25.
6
Late-onset Huntington's disease: diagnostic and prognostic considerations.迟发性亨廷顿病:诊断和预后考虑。
Parkinsonism Relat Disord. 2014 Jul;20(7):726-30. doi: 10.1016/j.parkreldis.2014.03.017. Epub 2014 Mar 27.
7
A liminal stage after predictive testing for Huntington disease.亨廷顿病预测性检测后的阈限阶段。
J Med Genet. 2017 Aug;54(8):511-520. doi: 10.1136/jmedgenet-2016-104199. Epub 2017 Jan 13.
8
[Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].[三核苷酸重复扩增数目在亨廷顿舞蹈病临床表现中的重要性]
Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82.
9
Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis.亨廷顿病发病年龄和行为表现:Enroll-HD 队列分析。
Clin Genet. 2021 Jan;99(1):133-142. doi: 10.1111/cge.13857. Epub 2020 Oct 16.
10
Juvenile onset Huntington's disease--clinical and research perspectives.青少年型亨廷顿舞蹈病——临床与研究视角
Ment Retard Dev Disabil Res Rev. 2001;7(3):153-7. doi: 10.1002/mrdd.1022.

引用本文的文献

1
Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease.在治疗亨廷顿舞蹈病舞蹈症的ARC-HD研究中,氘代丁苯那嗪高剂量与低剂量每日用药的安全性和有效性对比
CNS Drugs. 2025 Feb;39(2):185-195. doi: 10.1007/s40263-024-01139-3. Epub 2025 Jan 18.
2
Sex contribution to average age at onset of Huntington's disease depends on the number of (CAG) repeats.性别的影响取决于亨廷顿病发病年龄的(CAG)重复次数。
Sci Rep. 2024 Jul 8;14(1):15729. doi: 10.1038/s41598-024-64105-5.
3
Modifiable factors associated with Huntington's disease progression in presymptomatic participants.与亨廷顿病在症状前参与者中进展相关的可修饰因素。
Ann Clin Transl Neurol. 2024 Jul;11(7):1930-1941. doi: 10.1002/acn3.52120. Epub 2024 Jun 10.
4
Sex-Specific Differences in the Progression of Huntington's Disease Symptoms - A National Study in China.亨廷顿舞蹈症症状进展中的性别差异——一项中国全国性研究
Neuroepidemiology. 2025;59(1):78-86. doi: 10.1159/000539131. Epub 2024 May 30.
5
Targeting -Methyl-d-Aspartate Receptors in Neurodegenerative Diseases.靶向神经退行性疾病中的 N-甲基-D-天冬氨酸受体。
Int J Mol Sci. 2024 Mar 27;25(7):3733. doi: 10.3390/ijms25073733.
6
Large animal models for Huntington's disease research.用于亨廷顿病研究的大动物模型。
Zool Res. 2024 Mar 18;45(2):275-283. doi: 10.24272/j.issn.2095-8137.2023.199.
7
A Practical Guide for Clinical Approach to Patients With Huntington's Disease in Korea.韩国亨廷顿舞蹈病患者临床诊疗实用指南
J Mov Disord. 2024 Apr;17(2):138-149. doi: 10.14802/jmd.24040. Epub 2024 Mar 12.
8
Gene-dosage- and sex-dependent differences in the prodromal-Like phase of the F344tgHD rat model for Huntington disease.亨廷顿病F344tgHD大鼠模型前驱期样阶段的基因剂量和性别依赖性差异。
Front Neurosci. 2024 Feb 7;18:1354977. doi: 10.3389/fnins.2024.1354977. eCollection 2024.
9
Sex differences in sleep architecture in a mouse model of Huntington's disease.亨廷顿病小鼠模型中睡眠结构的性别差异。
J Neurosci Res. 2024 Jan;102(1):e25290. doi: 10.1002/jnr.25290.
10
Exploring Huntington's Disease Diagnosis via Artificial Intelligence Models: A Comprehensive Review.通过人工智能模型探索亨廷顿舞蹈症诊断:全面综述
Diagnostics (Basel). 2023 Dec 3;13(23):3592. doi: 10.3390/diagnostics13233592.

本文引用的文献

1
Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.亨廷顿蛋白编码的多聚谷氨酰胺扩展在体外和体内形成淀粉样蛋白聚集体。
Cell. 1997 Aug 8;90(3):549-58. doi: 10.1016/s0092-8674(00)80514-0.
2
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.神经元核内包涵体的形成是亨廷顿舞蹈症突变转基因小鼠神经功能障碍的基础。
Cell. 1997 Aug 8;90(3):537-48. doi: 10.1016/s0092-8674(00)80513-9.
3
HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain.HIP1是酿酒酵母Sla2p的人类同源物,在大脑中与膜相关的亨廷顿蛋白相互作用。
Nat Genet. 1997 May;16(1):44-53. doi: 10.1038/ng0597-44.
4
Longitudinal change in basal ganglia volume in patients with Huntington's disease.亨廷顿舞蹈症患者基底神经节体积的纵向变化
Neurology. 1997 Feb;48(2):394-9. doi: 10.1212/wnl.48.2.394.
5
Trinucleotide repeat length and clinical progression in Huntington's disease.亨廷顿舞蹈病中的三核苷酸重复序列长度与临床进展
Neurology. 1996 Feb;46(2):527-31. doi: 10.1212/wnl.46.2.527.
6
Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.亨廷顿舞蹈病中三核苷酸重复序列与神经病理学变化之间的关系。
Ann Neurol. 1996 Jan;39(1):132-6. doi: 10.1002/ana.410390120.
7
Duration of illness in Huntington's disease is not related to age at onset.亨廷顿舞蹈症的病程与发病年龄无关。
J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):98-100. doi: 10.1136/jnnp.56.1.98.
8
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.亨廷顿舞蹈病中三核苷酸重复序列扩增与表型变异的关系。
Nat Genet. 1993 Aug;4(4):393-7. doi: 10.1038/ng0893-393.
9
Trinucleotide repeat length instability and age of onset in Huntington's disease.亨廷顿病中三核苷酸重复序列长度不稳定性与发病年龄
Nat Genet. 1993 Aug;4(4):387-92. doi: 10.1038/ng0893-387.
10
Trinucleotide repeat length and rate of progression of Huntington's disease.亨廷顿舞蹈症的三核苷酸重复序列长度与疾病进展速率
Ann Neurol. 1994 Oct;36(4):630-5. doi: 10.1002/ana.410360412.

亨廷顿舞蹈症的病程基于发病年龄的差异。

Differences in duration of Huntington's disease based on age at onset.

作者信息

Foroud T, Gray J, Ivashina J, Conneally P M

机构信息

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis 46202, USA.

出版信息

J Neurol Neurosurg Psychiatry. 1999 Jan;66(1):52-6. doi: 10.1136/jnnp.66.1.52.

DOI:10.1136/jnnp.66.1.52
PMID:9886451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1736160/
Abstract

OBJECTIVES

Data from a sample of 2494 patients affected with Huntington's disease (HD), collected as part of the National Research Roster for Huntington Disease Patients and Families, were examined to determine if there was a relation between age at onset and duration of illness.

METHODS

Sufficient data for inclusion in analysis was available from 2068 patients, of whom 828 were deceased and 1240 were living. The median duration of disease was 21.4 years with a range of 1.2 to 40.8 years. Patients were categorised into one of four groups based on their age at onset.

RESULTS

Significant differences in duration based on the age at onset were found (p<0.025), with juvenile and late onset patients with HD having shorter duration of illness compared with those with an onset between 20-49 years.

CONCLUSIONS

Duration of disease is influenced by the age at symptom onset with juvenile and late onset patients having the shortest duration.

摘要

目的

作为全国亨廷顿病患者及家庭研究名册的一部分,收集了2494例亨廷顿病(HD)患者的样本数据,以确定发病年龄与病程之间是否存在关联。

方法

2068例患者有足够的数据纳入分析,其中828例已死亡,1240例尚在世。疾病的中位病程为21.4年,范围为1.2至40.8年。根据发病年龄将患者分为四组之一。

结果

发现基于发病年龄的病程存在显著差异(p<0.025),与发病年龄在20-49岁之间的患者相比,青少年型和晚发型HD患者的病程较短。

结论

疾病病程受症状发作年龄的影响,青少年型和晚发型患者的病程最短。